000 01134 a2200313 4500
005 20250512084804.0
264 0 _c19851029
008 198510s 0 0 eng d
022 _a0041-008X
024 7 _a10.1016/0041-008x(85)90380-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCarrington, C D
245 0 0 _aParaoxon reversibly inhibits neurotoxic esterase.
_h[electronic resource]
260 _bToxicology and applied pharmacology
_cJun 1985
300 _a175-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBinding, Competitive
650 0 4 _aCarboxylic Ester Hydrolases
_xantagonists & inhibitors
650 0 4 _aCatalysis
650 0 4 _aChickens
650 0 4 _aFemale
650 0 4 _aIsoenzymes
_xantagonists & inhibitors
650 0 4 _aIsoflurophate
_xanalogs & derivatives
650 0 4 _aParaoxon
_xpharmacology
700 1 _aAbou-Donia, M B
773 0 _tToxicology and applied pharmacology
_gvol. 79
_gno. 1
_gp. 175-8
856 4 0 _uhttps://doi.org/10.1016/0041-008x(85)90380-1
_zAvailable from publisher's website
999 _c4055087
_d4055087